Princess Therese of Liechtenstein (PhD in Cancer Immunology and Immunotherapy at University College London) is currently managing strategic projects at the Healthcare Strategy Realization Office of Merck KGaA in Darmstadt.
Prior to this she worked as a manager at Industrie- und Finanzkontor in Vaduz, Liechtenstein, a leader in the field of wealth preservation.
During her scientific career Princess Therese performed research studies as a biologist in the field of cancer immunotherapy and worked at University College London, UK, and at Navarrabiomed Fundación Miguel Servet, in Pamplona, Spain. Her work led to the publication of several biomedical papers and patents in the field of Cancer Immunotherapy.
Princess Therese additionally holds a BA degree in Biology and Business Studies from New York University and a MSc degree in Biomedical Sciences from the University of Amsterdam.